Collins et al., “Postional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma”, Natl. Acad. of Sci., vol. 95, pp. 8703-8708 (1998).* |
Weissenbach, GenBank Acc. No. Z66824.* |
Hudson, GenBank Acc. No. G07189.* |
Anzick, et al., “AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer,” Science, 277(5328):965-8 (1997). |
Bärland, et al., “Increased Copy No. at 17q22-q24 by CGH in Breast Cancer is Due to High-Level Amplification of Two Separate Regions,” Genes, Chromosomes & Cancer, 20:372-376 (1997). |
Benz, et al., “Expression of c-myc, c-Ha-ras1, and c-erbB-2 proto-oncogenes in normal and malignant human breast epithelial cells,” J Natl Cancer Inst, 81(22):1704-9 (1989). |
Berns, et al., “Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment,” Gene, 159(1):11-18 (1995). |
Bischoff, et al., “A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers,” EMBO Journal, 17:3052-3065 (1998). |
Bockmuhl, et al., “[Genetic screening of head-neck carcinomas using comparative genomic hybridization (CGH)]” Laryngorhinootologie, 75(7):408-14 (1996). |
Borg, et al., “ERBB2 amplification in breast cancer with a high rate of proliferation,” Oncogene, 6(1):137-43 (1991). |
Borg, et al., “c-myc Amplification is an Independent Prognostic Factor in Postmenopausal Breast Cancer,” Int. J. Cancer, 51:687-691 (1992). |
Brinkmann, et al., “The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines,” Genome Res, 6(3):187-94 (1996). |
Collins, et al., “Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma,” Proc. Natl. Acad. Sci USA, 95:8703-8708 (1998). |
Courjal, et al., “DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours,” Br J Cancer, 74(12):1984-9 (1996). |
Courjal, et al., “Mapping of DNA Amplifications at 15 Chromosomal Localizations in 1875 Breast Tumors: Definition of Phenotypic Groups,” Cancer Research, 57:4360-4367 (1997). |
Dib, et al., “A comprehensive genetic map of the human genome based on 5,264 microsatellites,” Nature, 380(6570):152-4 (1996). |
Dutrillaux, et al., “Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes,” Cancer Genet Cytogenet., 49(2):203-17 (1990). |
Gaudray, et al., “DNA amplification at 11q13 in human cancer: from complexity to perplexity,” Mutat Res, 276(3):317-28 (1992). |
Guan, et al., “Hybrid Selection of Transcribed Sequences from Microdissected DNA: Isolation of Genes within an Amplified Region at 20q11-q13.2 in Breas Cancer,” Cancer Research, 56:3446-3450 (1996). |
Isola, et al., “Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer,” Am J Pathol, 147(4):905-11 (1995). |
Iwabuchi, et al., “Genetic analysis of benign, low-grade, and high-grade ovarian tumors,” Cancer Res, 55(24):6172-80 (1995). |
Kallioniemi, et al., “Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization,” Proc Natl Acad Sci USA, 91(6):2156-60 (1994). |
Letovsky, et al., “GDB: the Human Genome Database,” Nucleic Acids Res, 26(1):94-9 (1998). |
Muleris, et al., “Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique,” Genes Chromosomes Cancer, 10(3):160-70 (1994). |
Olson, et al., “A common language for physical mapping of the human genome,” Science, 245(4925):1434-5 (1989). |
Reid, et al., “A 1-Mb Physical Map and PAC Contig of the Imprinted Domain in 11p15.5 That Contains TAPA1 and the BWSCR1/WT2 Region,” Genomics, 43:366-375 (1997). |
Reznikoff, et al., “Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells,” Genes Dev, 8(18):2227-40 (1994). |
Savelieva, et al., “20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells,” Oncogene, 14(5):551-60 (1997). |
Schlegel, et al., “Comparative genomic in situ hybridization of colon carcinomas with replication error,” Cancer Res, 55(24):6002-5 (1995). |
Sen, et al., “A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines,” Oncogene, 14(18):2195-200 (1997). |
Smith HS, et al., “Molecular and cellular lesions associated with breast cancer progression,” Breast Cancer Res. Treat., 18 Suppl 1:S51-4 (1991). |
Solinas-Toldo, et al., “Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances,” Genes Chromosomes Cancer, 20(4):399-407 (1997). |
Solinas-Toldo, et al., “Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality,” Proc Natl Acad Sci USA, 94(8):3854-9 (1997). |
Stokke, et al., “A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis,” Genomics, 26(1):134-7 (1995). |
Tanner, et al., “Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications,” Clin Cancer Res, 1(12):1455-61 (1995). |
Tanner, et al., “Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes,” Cancer Res, 54(16):4257-60 (1994). |
Tanner, et al., “Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer,” Cancer Res, 56(15):3441-5 (1996). |
Tirkkonen, et al., “Molecular Cytogenetics of Primary Breast Cancer by CGH,” Genes, Chromosomes & Cancer, 21:177-184 (1998). |
Van de Vijver and Nusse, “The molecular biology of breast cancer,” Biochim Biophys Acta, 1072(1):33-50 (1991). |
Weissenbach, et al., “A second-generation linkage map of the human genome,” Nature, 359(6398):794-801 (1992). |
Williamson, et al., “Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors,” Genomics, 35(1):262-4 (1996). |